Compound notoginseng composition for treating cardiac and cerebral vascular diseases

A technology for cardiovascular and cerebrovascular diseases and a composition, which is applied in the field of medicine and can solve the problems of inconvenience in taking, large toxic and side effects, and the like

Inactive Publication Date: 2006-05-17
张文芳
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the past, the prevention and treatment of cerebral ischemia mostly focused on dilating cerebral blood vessels and increasing cerebral blood flow to reduce the scope of cerebral infarction or improve neurological function. widely used on

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0018] Prescription ratio:

[0019] (1) 1 part of Panax notoginseng total saponins 1 part of total flavonoids of hawthorn leaves

[0020] (2) 1 part of Panax notoginseng saponins, 2 parts of total flavonoids in hawthorn leaves

[0021] 1. Preparation of total saponins of notoginseng and total flavonoids of hawthorn leaves aqueous injection.

[0022] According to the ratio of prescription 1 or 2, the total saponins of Panax notoginseng are dissolved with an appropriate amount of sodium hydroxide, and the pH value is adjusted to 6.0-7.5. The above-mentioned hawthorn leaf flavonoids are dissolved in an appropriate amount of water for injection to make 20mg / ml, and the pH value is adjusted to 6.0. -7.5, adding an appropriate amount of antioxidants. After filtering through a microporous membrane, add water for injection to the specified amount, fill it into a 5ml ampoule bottle, melt seal / cap it, and pack it after passing the inspection.

[0023] 2. Preparation of total saponins...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention discloses one kind of compound preparation of haw leaf flavonid and total arasaponin and with obvious curative effect on cardiac and cerebral vascular diseases, especially on cerebral apoplexy.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a preparation with significant curative effect for treating cardiovascular and cerebrovascular diseases, which takes total flavonoids of hawthorn leaves and total saponins of notoginseng as main components, and a preparation method thereof. Background technique [0002] Cardiovascular and cerebrovascular diseases are frequent diseases of middle-aged and elderly people, especially cerebral ischemia, which is the most important disease of vascular encephalopathy, and has the characteristics of high mortality and high disability rate. In the past, the prevention and treatment of cerebral ischemia mostly focused on dilating cerebral blood vessels and increasing cerebral blood flow to reduce the scope of cerebral infarction or improve neurological function. widely applied. Therefore, finding new drugs that can effectively prevent and treat cerebral ischemic diseases is a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/734A61K9/00A61P9/10
Inventor 张文芳
Owner 张文芳
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products